• 国外看中国科技:中国隧道技术发展迅速享誉世界 2020-01-10
  • 来自学的大学课本根据马克思著作编写的“辩证唯物主义与历史唯物主义”。 2020-01-07
  • 国家开发银行获第十二届人民企业社会责任奖年度企业奖 2020-01-07
  • 滴滴公布阶段整改措施 零容忍整治“人车不符” 2019-12-27
  • 老人凌晨4点穿街过巷 ,神秘男子为何悄悄跟在身后? 2019-12-20
  • 十九大代表陈小玲:扎根基层 服务人民 2019-12-19
  • 一带一路人民币国际化做好分析总结是最重要工作,国际竞争需要 2019-12-19
  • 秒杀售罄!习酒狗年生肖酒遭遇疯抢生肖 狗年 2019-12-17
  • 融入长三角一体化新进程 昆山按下快进键 2019-12-17
  • 山西10年收治6万余戒毒人员 构建大戒毒工作格局 2019-12-08
  • 弘扬“上海精神” 构建命运共同体 2019-12-08
  • Xi stresses building elite maritime force during navy inspection 2019-12-06
  • 【专题】2018高考来了,你准备好了吗? 2019-12-06
  • 租购并举渐入佳境构建楼市阶梯型消费 2019-11-25
  • 2月各地领导答复网民留言1.3万项 四川回复量第二 2019-11-23
  • ENGLISH

    六合彩惠泽管家婆 www.ghhym.tw Having beenthe Northwest Epidemic Prevention Bureau, Lanzhou Institute of Biological Products Co., Ltd ("the company") was established in 1934. The Company nowis one of the major subsidiary biological hi-tech enterprises under China National Biotech Group Company Limited (CNBG),which is the member enterprise of SINOPHARM managed by the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council in China. In 2013, SINOPHARM became the first and only Chinese pharmaceutical corporation which listed in the Fortune Global 500.

    The company covers a total land area of 430,000 square meters and has total assets of more than three billion yuan (RMB). It is mainly engaged in development andmanufacturing of biological products (vaccines, toxins, antitoxins, blood products and human in vitro diagnostic reagents, etc.), being a key enterprise in the field of biological products in the country. It is the only large high-tech biological company in the northwestern region of the country; an important national scientific research organization in the fields of medical microbiology, immunology and molecular biology; a state-certified technical center of enterprise, a national technology innovation model companyand vaccine engineering research center of Gansu Province; a high-tech industrialized model unit of Gansu Province; a post-doctor working station under the Ministry of Personnel authorized by the Academic Degrees Committee of the State Council to confer Master's degree; an appointed supplier of rehabilitation drugs for the "Tomorrow Plan" Project by the Ministry of Civil Affairs, undertaking the responsibility of central reserve of biological products against emergencies, disasters and epidemics. Moreover, the company is also a training base for the National Institute of Food and Drug Control, CFDA.

    Since its establishment, the company has beenalways aspromoting the health level of people for the purposeanddedicated to the research and development of biological products. It has made positive contributions to the health and epidemic prevention of Chinese peopleandyielded good economic and socialbenefits. Since thereform and opening-up from 1978 in China,the total assets of the companyincreased from 18.61 milliontomore than 3 billionRMB, which increased by 161 times; the total profit increased from 1.35 million to 420 millionRMB, which increased by 311 times. Theproductsowned by the company increased from8old varieties in the earlydays of liberation(around 1950s) to now about100 ofvarieties.The company established a perfect quality assurance system.All of the products and workshops conform to GMP standard by CFDA's inspection. The annual output ofall kinds of products is nearly 100 million doses, and these products have covered all provinces, municipal and autonomous regions in Chinaexcept Taiwan.

    Since the reform and opening-up from 1978,the company has gained fruitful achievements in scientific research and 100 provincial-level orabovescientific and technological awards.Theindustrialization of scientific research achievementshas not only yielded good economic benefits, but also effectively improved the level of the biotechnology industry of China.

    The company has been selected as one of top50among 100 Gansu Excellent Industry Enterprisesfor consecutive years since 2002, and also one of top 30among Top 100 Taxpayers of Gansu Provincefor consecutive years since 2007.

    联系我们
    提供给您最好的
    联系我们
    • 联系电话: 0931-8316041
    • 不良反应和产品咨询:
      0931-8340311
    • 举报邮箱:
      [email protected]
  • 国外看中国科技:中国隧道技术发展迅速享誉世界 2020-01-10
  • 来自学的大学课本根据马克思著作编写的“辩证唯物主义与历史唯物主义”。 2020-01-07
  • 国家开发银行获第十二届人民企业社会责任奖年度企业奖 2020-01-07
  • 滴滴公布阶段整改措施 零容忍整治“人车不符” 2019-12-27
  • 老人凌晨4点穿街过巷 ,神秘男子为何悄悄跟在身后? 2019-12-20
  • 十九大代表陈小玲:扎根基层 服务人民 2019-12-19
  • 一带一路人民币国际化做好分析总结是最重要工作,国际竞争需要 2019-12-19
  • 秒杀售罄!习酒狗年生肖酒遭遇疯抢生肖 狗年 2019-12-17
  • 融入长三角一体化新进程 昆山按下快进键 2019-12-17
  • 山西10年收治6万余戒毒人员 构建大戒毒工作格局 2019-12-08
  • 弘扬“上海精神” 构建命运共同体 2019-12-08
  • Xi stresses building elite maritime force during navy inspection 2019-12-06
  • 【专题】2018高考来了,你准备好了吗? 2019-12-06
  • 租购并举渐入佳境构建楼市阶梯型消费 2019-11-25
  • 2月各地领导答复网民留言1.3万项 四川回复量第二 2019-11-23
  • 小区开快递公司赚钱吗 今日湖北快三走势图 福彩3d走势图连带线 实力单双中特118 胜平负 新浪棋牌送38元版 易点彩票游戏 北京十一选五的出奖号 球探网足球前瞻分析 学围棋